MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)
Clinical trial NCT03846219 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03846219
- Sponsor
- Immunic AG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-28
- Primary completion
- 2020-04-24
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.